Rithm Acquisition Corp. (RAC.U) Prices $200M IPO
by Nicholas Alan Clayton on 2025-02-26 at 6:59pm

Rithm Acquisition Corp. (NYSE:RAC.U) announced the pricing of its $200 million IPO and its units are expected to begin trading on the NYSE under the symbol “RAC.U”, Thursday, February 27, 2025.

The new SPAC intends to search for a target in the financial services and real estate sectors where its management team has particular operational experience.

The team is led by CEO and Chairman Michael Nierenberg and CFO Varun Wadhawan. Elizabeth Fascitelli and Gary Kalk will serve as Directors.

Total SPAC deal count for 2025 year-to-date is now 13. This offering is expected to close on Friday, February 28, 2025.


Citigroup Global Markets Inc., BTIG, LLC and UBS Investment Bank are serving as the joint book-running managers for the offering. Davis Polk & Wardwell LLP is serving as Issuer’s Counsel with Kirkland & Ellis LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.

Recent Posts
by Nicholas Alan Clayton on 2025-02-27 at 8:21am

At the SPAC of Dawn  One more SPAC will join the 2025 party as Rithm (NYSE:RAC.U) priced its $200 million IPO overnight bringing the year’s count to 13 new searching SPACs. There’s also been some movement from SPACs of Christmas present to Christmas past as serial lead on the dMY SPACs Niccolo de Masi has...

by Nicholas Alan Clayton on 2025-02-26 at 6:59pm

Rithm Acquisition Corp. (NYSE:RAC.U) announced the pricing of its $200 million IPO and its units are expected to begin trading on the NYSE under the symbol “RAC.U”, Thursday, February 27, 2025. The new SPAC intends to search for a target in the financial services and real estate sectors where its management team has particular operational...

by Nicholas Alan Clayton on 2025-02-26 at 8:18am

At the SPAC of Dawn  The biotech sector has represented a significant portion of SPAC dealflow over the past five years, but signs are showing that it may take some previously unanticipated hits from the transition to the new US administration. Ginkgo Bioworks (NYSE:DNA) struck one of 2021’s headline deals at a $15 billion valuation...

by Kristi Marvin on 2025-02-25 at 7:44am

This week, in a special edition of the SPACInsider Podcast, we focus on the private markets with PM Insights founder and CEO Nick Fusco. Nick weighs in with his thoughts on the major trends shaping private market valuations today and how the market has evolved since the pandemic years. Plus, how difficult is it to...

by Nicholas Alan Clayton on 2025-02-25 at 7:40am

At the SPAC of Dawn  SPACs have been a frequent target of litigators over the past half-decade, but yesterday saw the unusual news of two de-SPACs teaming up for a court action of their own. The two are perhaps an unsurprising pair in conservative social media platforms Trump Media (NASDAQ:DJT) and Rumble (NASDAQ:RUM), but such...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved